Humayou Qtr2 Fin

30
Qtr 2,2010-2011  ASTER BUSINESS UNIT KNIGHTS-B LAHORE II HUMAYOU MUSTAFA  ARM 

Transcript of Humayou Qtr2 Fin

Page 1: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 1/30

Qtr 2,2010-2011

ASTER BUSINESS UNITKNIGHTS-B LAHORE II

HUMAYOU MUSTAFA ARM

Page 2: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 2/30

Break through

Qtr 1, 2010-20111. Prof.Mumtaz Hasan.2. Dr khurshd developed on flurfing and lipilow3. Dr Abdul Aleem asif Rx lipilow 10mg and 20mg4. Dr Shahid Mumtaz Rx lipilow 20m5. Dr Imtiaz Hasan Rx lipilow 10mg6. Dr Saima Naz Rx lipilow 20mg7. Prof.Zubair Akram on lipilow 20mg

8. Dr Yousaf Nadeem developed on flurfin9. Dr Samar kazmi developed on lipilow 20mg10.Dr Rasheed ch Rx lipilow 10mg

Page 3: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 3/30

Achievement QTR ± 1, 10 -11

L HR ± II Target Ach. % of Ach.

Total Value allProducts 3076 2146 70%

Page 4: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 4/30

Page 5: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 5/30

History of Sales (last 3 Months)C alan- Units

Product July August September

40mg 263 289 290

80mg 241 174 233

SR 4059 3960 5651

BrandValue

255916 245703 341819

Investment 0 0 0

% of Sales 0 0 0

Page 6: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 6/30

F indings

Not pr o perly de tai led N

ew a

reas

f o

r a

ll o

f my t e

am member No aca dem ic d iscussions reg a rd in g C a l an w ith

Docto r s

Page 7: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 7/30

TGT QTR2

OC T 6937NO V 6937DE C 6937

Total Q2 20811

Page 8: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 8/30

Action PlanDATE DR NAME AREA TYPE OF

AC TINO OF PART

EXP R O I/M

21-10-10 DR A LTAF C HEMA GARDENTOW N

S L IDE L EC T 8-10 4000 200 ± 225

16-11-10 DR HUMAY O U

RASHEED

SANDHA S L ID L EC T 8-10 2000 100 ± 120

11-11-10 DR M A F ZAL SAHI W AL S L IDE L EC T 5-8 2000 100-150

26-11-10 DR SA L EEMAQAISARA

L AHO RE F MH S L IDE L EC T 20-25 4500 200-250

14-12-10 DR SHAHIDDO GAR

RENA L AKHURD

S L IDE L EC T 8-10 2000 120-150

Total 13500 900packs/m

Page 9: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 9/30

Lipilow

Product Target Ach. % of Ach.

10mg 1683 1434 85

20mg 645 524 81

40mg 309 33 11

Brand Value 223399 68%

Investment 47626

% of Sales 21

Page 10: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 10/30

History of Sales (last 3 Months)LIPILOW - Units

Product July August September

L IPILOW 10 586 416 428

L IPILOW 20 216 155 135

L IPILOW 40 13 11 9

Brand Value 91480 65615 63045

Investment 42195 1855 3576

% of Sales 46 2 5

Page 11: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 11/30

F indings

No o rder fr o m d i pO u r sahi w a l sa le is ge ttin g d o w n be caus e dr S a eed d o g a r is not pre sc r i b in g l i p i l o w

Page 12: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 12/30

TGT O F NEXT QTR

OC T 587

NO V 614

DE C 614

TO

ATAL

1815

Page 13: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 13/30

Action PlanDATE DR NAME AREA TYPE OF

AC TI

NO OF

PART

EXP R O I/M

19-10-10 DR DANISHJANJUA

SAHI W AL F AMIL YDINNER

1 3000 L IPI 10MG150 PA C S

30-10-10 DR SHAHIDMUMTAZ

JAI L RO AD F AMIL YDINNER

1 2000 L IPI 20MG70 PA C S

MO

NTHL

Y DR MUMTAZHASAN SHADMANC

HOL

ESTRO

L C AMP 1 2500L

IPI 10MG50 PA C S

MO NTHL

YDR R O HI NAZDR W AL I ULL AH

SZH SAMP L EDO NATI O N

2 --- L IPI 10MG60 PA C S

DR IMTIAZ HASAN JAI L RO AD CL INIC REN O VATI O

N

1 10000 L IPI 10MG150P/M

FO R SIXMO NTHS

TO TAL RS-17500

L IPI 10-410L IPI 20-50RS-45310

Page 14: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 14/30

SPIROMIDE

Product Target(V) Ach.(V) % of Ach.

SPIR O MIDE 1018917 870774 85%

Brand Value 870774Investment 0

% of Sales 0

Page 15: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 15/30

History of Sales (last 3 Months)Spiromide

Product July August September

Spiromide 5119 4628 5651

Brand Value 289497 261713 319564

Investment 0 0 0

% of Sales 0 0 0

Page 16: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 16/30

F indings

T h e pr o d uct w as not on pr o per f ocus

P r o d uct w as not co mple t ely de tai led in th e dr¶ s cha mber

No activiti e s

Page 17: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 17/30

TGT O F NEXT QTR

OC T 6336

NO V 6336

DE C 6402

TO TA L 19074

Page 18: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 18/30

Action Plan

DATE DR N AME AREA TY P E OF ACTI

N O OF P ART

EX P ROI/M

19-10-

10

DR BILAL

MAHIU DI N

P IC

JILLA NN I BLOCK

SLIDE

LECT

8-10 2000 200 ±250

20-11-10 DR SHAHZADTAWB DR ZAHIDSHAHEE N

P IC CCU1CCU2 CCU3

SLID LECT 8-10 2000 200 ±250

27-12- 10 DR KHAWAR SAEED SAHIWAL SLIDE LECT 8-10 2000 200

TOTAL 6000 700 P ACKS

Page 19: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 19/30

F LUR F IN

Product Target(V) Ach.(V) % of Ach.FL UR F IN 224366 51807 23%

Brand Value 51807Investment 3975

% of Sales 7%

Page 20: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 20/30

History of Sales (last 3 Months)F LUR F IN

Product July August September

FL UR F IN 51 288 48

Brand Value 6827 38554 6425

Investment 360 1560 2055

% of Sales 5 4 30

Page 21: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 21/30

TGT O F NEXT QTR

OC T 594

NO V 660

DE C 660

TO TA L 1914

Page 22: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 22/30

F indings

1. Less

C usto

mer on

Fl u

rf in

1. Dr P re sc r i be s f o r on ly 1-3 d a y s .

Page 23: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 23/30

Action Plan

1. P ROVIDE FLEX BA NN ER TO THE 4 P OTE N TIALCUSTOMERS OF EACH MIE AREA OF A N TIQUE

P HOTO¶S

2. O N E FLEX SCE N RY WILL C ost RS-1000/DOCTOR

3. CUSTOMER HAVE ABILITY TO RX 70 TO 80 P ACKS OF FLURFI N

4. DEVELO P Liaison WITH THE CHEMISTS

Page 24: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 24/30

Page 25: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 25/30

Any Innovative activity in

Qtr 1, 2010-2011Snooker Activity (15-p 6000/-)

New year diaries on LIPILOW for thesenior doctors of PI C only with pastedtheir name and our product name .(10---3000-/)

F arm house visit in Sahiwal. (5families----8000/-)

Page 26: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 26/30

Qtr 2 targetsP r o d uct P r ic e

C a l an -40mg 59.85

C a l an -80mg 96.70

C a l an -SR 240mg 53.43

Sere nac e 1.5mg 22.98

Sere nac e 5mg 20' s 17.83

Sere nac e 5mg 100' s 71.24

Sere nac e 10mg 56.70

Sere nac e Amp ou le s 127.06

Sere nac e Dr o p s 10.09

Sp i r o m i de-20mg 56.55

Li p i l o w 10mg 91.8

Li p i l o w 20mg 160.66

Li p i l o w 40mg 229.5

Fl u rf in 100mg 133.87

Sm a r t S a l t 80gm 34.00

Sm a r t S a l t 250gm 73.00

T ota l V a l u e

OCT

660

264

6937

310

891

396

211

188

99

6336

587 215

103

594

2838

426

1201222

N OV

759

264

6937

310

891

396

211

188

99

6336

614231

115

660

2838

469

1226924

DEC

759

264

6937

310

891

396

211

188

99

6402

614

231

115

660

2897

469

1232663

Page 27: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 27/30

RM Plan for Success in Qtr 2Daily Tgt MonitoringTo improve Institutional BusinessProper coverage of all listed customers to improve streetsales

Development of 5 customer in each week by all meanTo create the chain of activity in each areaTo increase professional competency of ff.Think how to achieve one day battleStarts to give 30 minute to my self for the prospecting of next weekIncrease the focus on sales interview and improve it

Page 28: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 28/30

C ustomers developed in 1 st Qtr Name Designation Area p/day Unit/comm Investment

Dr ShahidKarim

Senior registrar

Jinnah hosp 20 to 30 Lipi 10 30Lipi 20 100

40000

Dr MumtazHasan

RtedProfessor

Jail road 20 to30 Lipi 10 50 -------

Dr ImtiazHasan

Diab Jail road 50 to 60 Lipi 10 30 -------

Dr C olMansoor

Diab Jail road 10 to 15 Lipi 10 15 -------

Dr Abu Bakar Senior Reg Pic+shadman 20 to 30 Lipi 20 15 -------

Dr ShahidMumtaz

C ard Shadman 15 to 20 Lipi 10 30 -------

Page 29: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 29/30

F ocused customers for Qtr 2Name Spe Area p/day Product Act Unit/m Exp

Dr MumtazHasan

card shadman 25 Lipilow10mg

C holestrolcamp

50 2000

Dr ImtiazHasan

diab Jail road 50 Lipilow10mg

C linicrenovation

150 10000

Dr khawar saeed

Phy sahiwal 70 F lurfin Sampledonation

50 -----

Dr abdulaleem asif

card okara 40 Lipilow20mg

Sampledonation

30 -----

Dr yousaf nadeem

dent Town ship 30 flurfin RTD 40 1500

Dr shahidmumtaz

card shadman 25 Lipilow10mg

F amilydinner

80 3500

Page 30: Humayou Qtr2 Fin

8/8/2019 Humayou Qtr2 Fin

http://slidepdf.com/reader/full/humayou-qtr2-fin 30/30

C ommitment!

100%Insha Allah!